Slow-release hydrogel aids immunotherapy for cancer

An immunotherapy drug embedded in a slow-release hydrogel invented at Rice University in collaboration with the University of Texas Health Science Center at Houston (UTHealth) appears to be highly effective at killing cancer ...

New big data approach predicts drug toxicity in humans

Researchers can now predict the odds of experimental drugs succeeding in clinical trials, thanks to a new data-driven approach developed by Weill Cornell Medicine scientists. The method detects toxic side effects that may ...

New method optimizes outcomes for subjects in comparison tests

Clinical trials of new drugs or devices face a problem that most empirical inquiries don't: They must not only provide clear data about toxicity and efficacy but also try to maximize the quality of treatment for all of the ...

page 11 from 26